S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
How major US stock indexes fared Friday, 4/19/2024
The only accurate crypto trading system I know … (Ad)
Stock market today: Tumbling tech stocks drag Wall Street to the finish line of another losing week
American Express profits jump 34%, helped by jump in new customers, higher spending
Biden’s $374B Giveaway Into This Sector (Ad)
American Express, Fifth Third rise; Netflix, PPG Industries fall, Friday, 4/19/2024
Intuitive Surgical Stock Can Trend Much Higher This Year 
The “Perfect Storm” for Gold (Ad)
3 Magnificent Seven Stocks Outperforming the Rest
Bargain Hunting: 3 Stocks With RSIs That Scream Oversold
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
How major US stock indexes fared Friday, 4/19/2024
The only accurate crypto trading system I know … (Ad)
Stock market today: Tumbling tech stocks drag Wall Street to the finish line of another losing week
American Express profits jump 34%, helped by jump in new customers, higher spending
Biden’s $374B Giveaway Into This Sector (Ad)
American Express, Fifth Third rise; Netflix, PPG Industries fall, Friday, 4/19/2024
Intuitive Surgical Stock Can Trend Much Higher This Year 
The “Perfect Storm” for Gold (Ad)
3 Magnificent Seven Stocks Outperforming the Rest
Bargain Hunting: 3 Stocks With RSIs That Scream Oversold
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
How major US stock indexes fared Friday, 4/19/2024
The only accurate crypto trading system I know … (Ad)
Stock market today: Tumbling tech stocks drag Wall Street to the finish line of another losing week
American Express profits jump 34%, helped by jump in new customers, higher spending
Biden’s $374B Giveaway Into This Sector (Ad)
American Express, Fifth Third rise; Netflix, PPG Industries fall, Friday, 4/19/2024
Intuitive Surgical Stock Can Trend Much Higher This Year 
The “Perfect Storm” for Gold (Ad)
3 Magnificent Seven Stocks Outperforming the Rest
Bargain Hunting: 3 Stocks With RSIs That Scream Oversold
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
How major US stock indexes fared Friday, 4/19/2024
The only accurate crypto trading system I know … (Ad)
Stock market today: Tumbling tech stocks drag Wall Street to the finish line of another losing week
American Express profits jump 34%, helped by jump in new customers, higher spending
Biden’s $374B Giveaway Into This Sector (Ad)
American Express, Fifth Third rise; Netflix, PPG Industries fall, Friday, 4/19/2024
Intuitive Surgical Stock Can Trend Much Higher This Year 
The “Perfect Storm” for Gold (Ad)
3 Magnificent Seven Stocks Outperforming the Rest
Bargain Hunting: 3 Stocks With RSIs That Scream Oversold
Free Trial

Day One Biopharmaceuticals (DAWN) Earnings Date, Estimates & Call Transcripts

→ The “Perfect Storm” for Gold (From Gold Safe Exchange) (Ad)
Free dawn Stock Alerts
$14.96
-0.79 (-5.02%)
(As of 04/19/2024 ET)
Compare
Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media

Earnings Summary

Upcoming
Earnings Date
May. 6Estimated
Actual EPS
(Feb. 26)
-$0.64 Missed By -$0.07
Consensus EPS
(Feb. 26)
-$0.57
Skip Charts & View Estimated and Actual Earnings Data
Earnings Per ShareRevenue

DAWN Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

DAWN Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Day One Biopharmaceuticals Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20243($0.71)($0.66)($0.68)
Q2 20243($0.71)($0.65)($0.68)
Q3 20243($0.72)($0.59)($0.65)
Q4 20243($0.74)($0.51)($0.62)
FY 202412($2.88)($2.41)($2.63)
Q1 20251($0.45)($0.45)($0.45)
Q2 20251($0.39)($0.39)($0.39)
Q3 20251($0.33)($0.33)($0.33)
Q4 20251($0.24)($0.24)($0.24)
FY 20254($1.41)($1.41)($1.41)

DAWN Earnings Date and Information

Day One Biopharmaceuticals last announced its earnings results on February 26th, 2024. The reported ($0.64) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.57) by $0.07. Day One Biopharmaceuticals has generated ($2.38) earnings per share over the last year (($2.38) diluted earnings per share). Earnings for Day One Biopharmaceuticals are expected to grow in the coming year, from ($2.66) to ($2.12) per share. Day One Biopharmaceuticals has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Monday, May 6th, 2024 based off prior year's report dates.

Day One Biopharmaceuticals Earnings History by Quarter

Export to Excel
DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript
5/6/2024
Estimated)		------- 
2/26/2024Q4 2023($0.57)($0.64)($0.07)($0.64)--
11/6/2023Q3 2023($0.60)($0.54)+$0.06($0.54)--
8/7/2023Q2 2023($0.60)($0.61)($0.01)($0.61)--
5/1/2023Q1 2023($0.59)($0.59)-($0.59)--
3/6/2023Q4 2022($0.57)($0.56)+$0.01($0.56)--
11/7/2022Q3 2022($0.53)($0.53)-($0.53)--
8/4/2022Q2 2022($0.49)($0.60)($0.11)($0.60)--
5/12/2022Q1 2022($0.39)($0.48)($0.09)($0.48)--    
3/7/2022Q4 2021($0.35)($0.36)($0.01)---
11/7/2021Q3 2021($0.28)($0.33)($0.05)($0.33)--
8/9/2021Q2 2021($0.32)($5.04)($4.72)$3.78--

Day One Biopharmaceuticals Earnings - Frequently Asked Questions

When is Day One Biopharmaceuticals's earnings date?

Day One Biopharmaceuticals has not confirmed its next earnings publication date, but the company's estimated earnings date is Monday, May 6th, 2024 based off last year's report dates. Learn more on DAWN's earnings history.

Did Day One Biopharmaceuticals beat their earnings estimates last quarter?

In the previous quarter, Day One Biopharmaceuticals (NASDAQ:DAWN) missed the analysts' consensus estimate of ($0.57) by $0.07 with a reported earnings per share (EPS) of ($0.64). Learn more on analysts' earnings estimate vs. DAWN's actual earnings.

How much profit does Day One Biopharmaceuticals generate each year?

Day One Biopharmaceuticals (NASDAQ:DAWN) has a recorded net income of -$188.92 million. DAWN has generated -$2.38 earnings per share over the last four quarters.

What is Day One Biopharmaceuticals's EPS forecast for next year?

Day One Biopharmaceuticals's earnings are expected to grow from ($2.66) per share to ($2.12) per share in the next year.


More Earnings Resources from MarketBeat

Related Companies:
Earnings Tools:
Earnings By Country:
Latest Articles:
This page (NASDAQ:DAWN) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners
The “Perfect Storm” for Gold
Gold Safe Exchange
Tiny Biotech Stock Wins $75 Billion Patent
Behind the Markets
Biden’s $374B Giveaway Into This Sector
DTI
He Is Giving Away Bitcoin
Crypto Swap Profits
SHOCKING Crypto Leak…
Crypto 101 Media
The #1 Crypto for 2024
InvestorPlace
How Biden has already won 2024
Porter & Company
Urgent alert: open this for a huge profit potential
Timothy Sykes